Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Yumanity Therapeutics, Inc. - Common Stock (NQ:YMTX)

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Dec 16, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Yumanity Therapeutics, Inc. - Common Stock

News headline image
Yumanity Therapeutics Declares Special Dividend In Connection with Proposed Asset Sale to Janssen and Merger with Kineta
From Yumanity Therapeutics Inc
Via GlobeNewswire
News headline image
Yumanity Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Developments
From Yumanity Therapeutics Inc
Via GlobeNewswire
News headline image
Yumanity Therapeutics Announces Effectiveness of Registration Statement on Form S-4 In Connection With Proposed Asset Sale to Janssen and Merger with Kineta, Inc.
Special Meeting of stockholders to approve asset sale and merger to be held on December 13, 2022 
From Yumanity Therapeutics Inc
Via GlobeNewswire
News headline image
YUMANITY THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Yumanity Therapeutics, Inc. - YMTX
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
YUMANITY THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Yumanity Therapeutics, Inc. - YMTX
From Kahn Swick & Foti, LLC
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.